PATEL SAMIR CHANDRAKANT has filed 4 insider transactions across 1 company since March 2025.
Most recent transaction: a grant/award of 18000 shares of Kalaris Therapeutics, Inc. ($KLRS) on April 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 10, 2025 | Kalaris Therapeutics, Inc. | $KLRS | PATEL SAMIR CHANDRAKANT | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 5,043,357 | 9999.99% | 0.36% |
| March 18, 2025 | Kalaris Therapeutics, Inc. | $KLRS | PATEL SAMIR CHANDRAKANT | Not found | A | Common Stock | 252000 | $0.00 | 352,800.0000 | 5,043,357 | 250.00% | 5.00% |
| March 18, 2025 | Kalaris Therapeutics, Inc. | $KLRS | PATEL SAMIR CHANDRAKANT | Not found | A | Common Stock | 100800 | $0.00 | 352,800.0000 | 5,043,357 | 40.00% | 2.00% |
| March 18, 2025 | Kalaris Therapeutics, Inc. | $KLRS | PATEL SAMIR CHANDRAKANT | Not found | A | Stock Option (right to buy) | 105913 | $0.00 | 105,913.0000 | 5,043,357 | 9999.99% | 2.10% |